{"id":135694,"date":"2026-06-30T17:14:46","date_gmt":"2026-06-30T11:44:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=135694"},"modified":"2026-10-07T09:12:43","modified_gmt":"2026-10-07T03:42:43","slug":"medplus-health-services-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2026\/","title":{"rendered":"Medplus Health Services Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q1 FY27"},"content":{"rendered":"
\n

META TITLE:<\/strong> Medplus Health Services Share Price Target 2026: Rs 624 to 744<\/p>\n

META DESCRIPTION:<\/strong> Medplus Health Services share price target 2026: Rs 624 to Rs 744 vs Rs 651.45. Share price today, stock analysis, buy or sell, bull and bear case, 12-month target.<\/p>\n

SLUG:<\/strong> medplus-health-services-share-price-target-2026<\/p>\n

PRIMARY KEYWORD:<\/strong> Medplus Health Services share price target<\/p>\n

SECONDARY KEYWORDS:<\/strong> Medplus Health Services share price today, Medplus Health Services stock analysis, Medplus Health Services buy or sell, Medplus Health Services share price forecast, Medplus Health Services stock price target 2027, Medplus Health Services price target, Medplus Health Services buy or sell<\/p>\n

LSI KEYWORDS:<\/strong> analyst consensus, bull case, bear case, 12-month target, PE multiple, EPS estimate, sector tailwinds, institutional holding, resistance level, FY27 outlook<\/p>\n<\/div>\n

Medplus Health Services Rs 651.45 (6 Oct 2026 close). 52-week range Rs 640.10 to Rs 1,022.20. Q1 FY27 revenue Rs 1,880 cr, up 22%; profit Rs 33 cr, down 22%.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Medplus Health Services share price target for 2026 is Rs 624 to Rs 744, which is between 4 percent below and 14 percent above the last close of Rs 651.45, with bull and bear cases of Rs 930 to Rs 1,054 and Rs 330 to Rs 390. Medplus Health Services reported Q1 FY27 consolidated revenue up 21.8 percent to Rs 1,879.6 crore but profit down 21.7 percent to Rs 33.17 crore, with operating EBITDA margin at 3.5 percent against 4.7 percent a year ago. The stock fell 17.8 percent on 22 July to a 52-week low after the results, the chain has 5,476 stores after adding 146, and the shares trade at 37 times earnings against an industry average of 64 times. No brokerage price target was available on the sources we track as of 6 October 2026, so every range below is a Univest research scenario.<\/p>\n<\/p><\/div>\n

The Medplus Health Services<\/a> share price target for 2026 is Rs 624 to Rs 744 in the Univest base case, with the stock at Rs 651.45 at the 6 October 2026 close. That is 36.3 percent below its 52-week high of Rs 1,022.20 and 1.8 percent above its 52-week low of Rs 640.10, and the stock moved down 16.9 percent over the past year. Medplus Health Services runs one of India’s largest pharmacy chains with 5,476 stores, a private label range and a diagnostics arm. Debt to equity is 0.72 and the company pays no dividend.<\/p>\n

Three things changed since the last update: Q1 FY27 results on 21 July showed profit down 22 percent, the stock fell 17.8 percent the next day, and franchise stores made up 131 of the 146 net additions. This Medplus Health Services stock analysis covers the Medplus Health Services share price today, the Medplus Health Services share price target for 2026, 2027 and 2030, the Q1 FY27 numbers, catalysts and risks, key price levels and a Medplus Health Services buy or sell view.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n